Tagged with BIO

Michele Oshman – Chief Patient Advocate and Head of the Patient Advocacy Center of Excellence, BIO
Tian Wenzhi – Chairman, Founder & CEO, ImmuneOnco Biopharma
Samsung Bioepis: Building a US Biosimilar Market That Lasts
Zydus: Beyond Generics, Into Rare
Christophe Delenta – President Europe, Sandoz
Pyung-suk Ki – CEO, ViGenCell
Patrick Jeukenne – Worldwide President, BD Pharmaceutical Systems
Generics and Biosimilars in the US: Margins, Market Access, & the Patent Expiry Wave
Still Indispensable: Why Global Pharma Keeps Investing in the US
Three 2026 FDA Reforms to Know
Sang Yup Lee – Distinguished Professor, Korea Advanced Institute of Science & Technology (KAIST); Former Vice Chair, National Bio Council
Realising the Global Value of Biosimilars: Turning Potential into Patient Access
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here